HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained release oral fampridine in the treatment of multiple sclerosis.

AbstractBACKGROUND:
Fampridine-SR is under submission as the first drug to be FDA approved with an indication specifically for multiple sclerosis symptoms. Compounded forms of the active agent of Fampridine-SR (4-aminopyridine) have been used in clinical practice for many years. Clinical trials have now been completed that demonstrate a robust capacity of the drug to meet stringent statistical and clinically meaningful end points.
OBJECTIVE:
To review the present understanding of multiple sclerosis, the proposed mechanism of action of Fampridine-SR in patients, the published data regarding its efficacy and safety in human clinical trials, and to discuss its potential clinical uses in MS.
RESULTS/CONCLUSION:
Fampridine-SR 10 mg twice a day has been shown to be safe and effective in improving the ambulation of patients with walking disability due to MS. It will probably find clinical application beyond this specific indication in a significant proportion of patients.
AuthorsNorman J Kachuck
JournalExpert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 10 Issue 12 Pg. 2025-35 (Aug 2009) ISSN: 1744-7666 [Electronic] England
PMID19586420 (Publication Type: Journal Article, Review)
Chemical References
  • Delayed-Action Preparations
  • Potassium Channel Blockers
  • 4-Aminopyridine
Topics
  • 4-Aminopyridine (pharmacology, therapeutic use)
  • Administration, Oral
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Multiple Sclerosis (drug therapy, physiopathology)
  • Potassium Channel Blockers (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: